Development of a Dynamic Multi-Protein Signature of Postoperative Delirium.
Aged
Biomarkers
/ blood
C-Reactive Protein
/ metabolism
Cytokines
/ blood
Delirium
/ blood
Disease Progression
Elective Surgical Procedures
/ adverse effects
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Male
Postoperative Complications
/ blood
Prospective Studies
Proteomics
/ methods
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
16 01 2019
16 01 2019
Historique:
received:
14
09
2017
accepted:
23
02
2018
pubmed:
13
3
2018
medline:
2
11
2019
entrez:
13
3
2018
Statut:
ppublish
Résumé
Delirium is common, morbid, and costly, yet its biology is poorly understood. We aimed to develop a multi-protein signature of delirium by identifying proteins associated with delirium from unbiased proteomics and combining them with delirium biomarkers identified in our prior work (interleukin [IL]-6 and IL-2). We used the Successful Aging after Elective Surgery (SAGES) Study of adults age ≥70 undergoing major noncardiac surgery (N = 560; 24% delirium). Plasma was collected preoperatively (PREOP) and on postoperative day 2 (POD2). In a nested matched case-control study involving 12 pairs of delirium cases and no-delirium controls, isobaric tags for relative and absolute quantitation-based (iTRAQ) mass spectrometry proteomics was applied to identify the top set of delirium-related proteins. With these proteins, we then conducted enzyme-linked immunosorbent assay (ELISA) confirmation, and if confirmed, ELISA validation in 75 matched pairs. Multi-marker conditional logistic regression was used to select the "best" PREOP and POD2 models for delirium. We identified three proteins from iTRAQ: C-reactive protein (CRP), zinc alpha-2 glycoprotein (AZGP1), and alpha-1 antichymotrypsin (SERPINA3). The "best" multi-protein models of delirium included: PREOP: CRP and AZGP1 (Bayesian information criteria [BIC]: 93.82, c-statistic: 0.77); and POD2: IL-6, IL-2, and CRP (BIC: 87.11, c-statistic: 0.84). The signature of postoperative delirium is dynamic, with some proteins important before surgery (risk markers) and others at the time of delirium (disease markers). Our dynamic, multi-protein signature for delirium improves our understanding of delirium pathophysiology and may identify patients at-risk of this devastating disorder that threatens independence of older adults.
Sections du résumé
Background
Delirium is common, morbid, and costly, yet its biology is poorly understood. We aimed to develop a multi-protein signature of delirium by identifying proteins associated with delirium from unbiased proteomics and combining them with delirium biomarkers identified in our prior work (interleukin [IL]-6 and IL-2).
Methods
We used the Successful Aging after Elective Surgery (SAGES) Study of adults age ≥70 undergoing major noncardiac surgery (N = 560; 24% delirium). Plasma was collected preoperatively (PREOP) and on postoperative day 2 (POD2). In a nested matched case-control study involving 12 pairs of delirium cases and no-delirium controls, isobaric tags for relative and absolute quantitation-based (iTRAQ) mass spectrometry proteomics was applied to identify the top set of delirium-related proteins. With these proteins, we then conducted enzyme-linked immunosorbent assay (ELISA) confirmation, and if confirmed, ELISA validation in 75 matched pairs. Multi-marker conditional logistic regression was used to select the "best" PREOP and POD2 models for delirium.
Results
We identified three proteins from iTRAQ: C-reactive protein (CRP), zinc alpha-2 glycoprotein (AZGP1), and alpha-1 antichymotrypsin (SERPINA3). The "best" multi-protein models of delirium included: PREOP: CRP and AZGP1 (Bayesian information criteria [BIC]: 93.82, c-statistic: 0.77); and POD2: IL-6, IL-2, and CRP (BIC: 87.11, c-statistic: 0.84).
Conclusion
The signature of postoperative delirium is dynamic, with some proteins important before surgery (risk markers) and others at the time of delirium (disease markers). Our dynamic, multi-protein signature for delirium improves our understanding of delirium pathophysiology and may identify patients at-risk of this devastating disorder that threatens independence of older adults.
Identifiants
pubmed: 29529166
pii: 4908656
doi: 10.1093/gerona/gly036
pmc: PMC6333936
doi:
Substances chimiques
Biomarkers
0
Cytokines
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
261-268Subventions
Organisme : NIA NIH HHS
ID : R01 AG051658
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041274
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG044518
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG035075
Pays : United States
Organisme : NIA NIH HHS
ID : K07 AG041835
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG057836
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG054259
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG031720
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001102
Pays : United States
Organisme : NCCIH NIH HHS
ID : T32 AT000051
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG030618
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG048600
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG061582
Pays : United States
Références
Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
J Am Geriatr Soc. 2015 Dec;63(12):2463-2471
pubmed: 26662213
J Am Med Dir Assoc. 2012 Nov;13(9):818.e1-10
pubmed: 22999782
Am J Geriatr Psychiatry. 2013 Dec;21(12):1190-222
pubmed: 24206937
J Am Geriatr Soc. 2014 Mar;62(3):518-24
pubmed: 24512042
Brain. 2006 Nov;129(Pt 11):3020-34
pubmed: 16987932
Rejuvenation Res. 2011 Dec;14(6):615-22
pubmed: 21978081
Brain. 2012 Sep;135(Pt 9):2809-16
pubmed: 22879644
Acta Neuropathol. 2010 Jun;119(6):737-54
pubmed: 20309566
Mol Cell Proteomics. 2004 Dec;3(12):1154-69
pubmed: 15385600
J Clin Exp Neuropsychol. 2010 Dec;32(10):1041-9
pubmed: 20446144
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774
BMC Anesthesiol. 2014 Dec 18;14:124
pubmed: 25580089
Psychiatry Investig. 2011 Dec;8(4):340-7
pubmed: 22216044
J Endocrinol. 2010 Feb;204(2):165-72
pubmed: 19934249
JAMA. 2010 Jul 28;304(4):443-51
pubmed: 20664045
J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1281-6
pubmed: 17234821
JAMA. 2012 Jul 4;308(1):73-81
pubmed: 22669559
BBA Clin. 2015 Oct 28;4:115-22
pubmed: 26675981
Biol Psychiatry. 2017 Jan 15;81(2):145-153
pubmed: 27160518
Transl Psychiatry. 2014 Nov 04;4:e477
pubmed: 25369144
J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10):1289-95
pubmed: 26215633
BMC Med Res Methodol. 2017 Jun 6;17(1):88
pubmed: 28587598
Mol Cancer Res. 2008 Jun;6(6):892-906
pubmed: 18567794